Preferred stimulant safer supply and associations with methamphetamine preference among people who use stimulants in British Columbia: Findings from a 2021 cross-sectional survey
•Stimulant safer supply can prevent toxicity deaths and promote wellbeing and dignity.•Crystal methamphetamine was the most preferred stimulant safer supply substance.•Preference for crystal methamphetamine differed by age, gender and drug use history.•One size fits all approaches to safer supply ar...
Gespeichert in:
Veröffentlicht in: | The International journal of drug policy 2023-10, Vol.120, p.104186, Article 104186 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | •Stimulant safer supply can prevent toxicity deaths and promote wellbeing and dignity.•Crystal methamphetamine was the most preferred stimulant safer supply substance.•Preference for crystal methamphetamine differed by age, gender and drug use history.•One size fits all approaches to safer supply are unlikely to be effective.•People who use drugs should be consulted in safer supply program design.
As safer supply programs expand in Canada, stimulant safer supply is often overlooked despite the harms and criminalization faced by people who use stimulants.
The 2021 Harm Reduction Client Survey was administered at 17 harm reduction sites around British Columbia, Canada. The survey included a question about what specific substance participants would want to receive as stimulant safer supply. We investigated preference of stimulant safer substance by looking at frequency of stated preference and by using multivariable logistic regression to understand factors associated with the most frequently chosen substance.
Of 330 participants who reported a stimulant safer supply preference, 58.5% (n = 193) chose crystal methamphetamine, 13% (n = 43) crack cocaine and 12.4% (n = 41) cocaine powder. The options that were available by prescription at the time of data collection were chosen by under 11% of participants (dextroamphetamine n = 21, methylphenidate n = 15). A preference for crystal methamphetamine was associated with being 29 and under compared to 50 and over (AOR: 3.96, 95% CI: 1.42–11.07, p-value: 0.01); self-identifying as a cis man versus a cis woman (AOR: 1.75, 95% CI: 1.03–2.97, p-value: 0.04); and using drugs every day (AOR: 15.43, 95% CI: 3.38–70.51, p-value: |
---|---|
ISSN: | 0955-3959 1873-4758 1873-4758 |
DOI: | 10.1016/j.drugpo.2023.104186 |